Dr. Aysha Khalid, MD

  • East Brunswick, NJ
  • Hematologist and oncologist
NPI1952522732PAC ID4486742624
Medicare services, 2024
35,388
Medicare patients, 2024
534
Part D claims, 2024
1,523
Publications
14
MIPS score, 2024
100
Practice address
629 Cranbury Rd, East Brunswick, NJ 08816
Practice phone
Call (732) 390-7750
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Astera Cancer Care - East Brunswick

East Brunswick, New Jersey

See all 8 affiliations

Find Dr. Khalid's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Aysha Khalid is a hematologist and oncologist in East Brunswick, New Jersey

Dr. Khalid practices at Astera Cancer Care - East Brunswick in East Brunswick, New Jersey.

Dr. Khalid's NPI, 1952522732, was assigned on May 1, 2007. Dr. Khalid graduated from Ross University School of Medicine in 2001. Dr. Khalid holds New Jersey license 25MA08205500.

NPI and contact details
Medicare PAC ID
4486742624
NPI enumeration date
May 1, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(732) 390-7750
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
51
Medical school graduation
2001

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Aysha Khalid practices at Astera Cancer Care - East Brunswick in East Brunswick, New Jersey

Dr. Khalid's primary practice is Astera Cancer Care - East Brunswick, at 629 Cranbury Rd, East Brunswick, NJ 08816 in Middlesex County. The practice phone is (732) 390-7750.

  • Astera Cancer Care - East Brunswick
    629 Cranbury Rd, East Brunswick, NJ 08816 · Middlesex CountyPhone(732) 390-7750

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Aysha Khalid is affiliated with 6 sites of care and 2 medical groups

Dr. Khalid's primary practice is Astera Cancer Care - East Brunswick in East Brunswick, New Jersey. Dr. Khalid is also affiliated with JFK University Medical Center. The medical group on file is Astera Cancer Care. Dmand AI also links Dr. Khalid to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

See all 8 affiliations for Dr. Khalid

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Aysha Khalid's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khalid practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Astera Cancer Care - East BrunswickAvailable with a free account
+5 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Khalid practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Aysha Khalid is one of 364 hematologists and oncologists in New Jersey

Hematology and oncology is Dr. Khalid's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Khalid is licensed in New Jersey.

Specialties and state licenses

  • Hematology and oncology, New JerseyPrimaryLicense 25MA08205500 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Khalid

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Aysha Khalid billed Medicare for 35,388 services in 2024

CMS data shows 35,388 Medicare services from Dr. Khalid across 25 procedure codes in 2024, for 534 Medicare patients. Medicare paid $247,596 for them.

Medicare services, 202435,388
Medicare patients534
Paid by Medicare$247,596
Procedure codes25

Dr. Khalid's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 25,7432024: 31,84624%
Office and hospital visits
2023: 1,6292024: 1,6994%
Tests and treatments
2023: 7002024: 7243%
Surgery
2023: 4082024: 51526%
Lab and pathology
2023: 5102024: 5002%
Other services
2023: 02024: 104

Where Dr. Khalid's Medicare services took place, 2024

  • In an office34,39097%
  • In a facility9983%

Dr. Khalid compared with the New Jersey median for hematologists and oncologists, 2024

  • Dr. Khalid
  • New Jersey median
Medicare services
35,388vs 1,51523.4 times
Medicare patients
534vs 33758% above
Part D claims
1,156vs 3783.1 times

Medians across 349 hematologists and oncologists in New Jersey with Dmand AI profiles that report each measure.

Dr. Khalid's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Khalid

Need commercial claims for Dr. Khalid?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Khalid and other hematologists and oncologists in New Jersey.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Aysha Khalid treated 534 Medicare patients in 2024, average age 76

CMS counts 534 Medicare patients who saw Dr. Khalid in 2024. The largest group is 65 to 74, with 196 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khalid's median patient age at 67, with 67% women.

Medicare patients, 2024534
Average age76
Average risk score2.34
Also on Medicaid11%

Dr. Khalid's Medicare patients by age, 2024

Dr. Khalid's Medicare patients by sex, 2024

  • Women32661%
  • Men20839%

Chronic conditions among Dr. Khalid's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Ischemic heart disease54%
  4. Diabetes52%
  5. Arthritis50%
  6. Cancer42%
  7. Chronic kidney disease41%
  8. Heart failure38%

Share of Medicare patients with each condition. A patient can have several.

Dr. Khalid's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women67%
  • Men29%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Aysha Khalid wrote 1,523 Medicare Part D claims in 2024

In 2024, Dr. Khalid wrote 1,523 Medicare Part D claims for 218 patients. 66% of them were for generic drugs. CMS names the drug for 1,156 of them, across 30 drugs with 11 or more claims each, at $1,369,013 in total drug cost. In 2023, CMS named 1,083 claims across 31 drugs.

Part D claims, 20241,523
Drugs named by CMS30
Total drug cost$1.4M
Part D patients218

Dr. Khalid's Part D claims by kind of drug, 2024

  • Generic1,010 claims66%
  • Brand-name513 claims34%

Dr. Khalid's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Khalid's Part D claims, 2024

  • Opioids4%60 of 1,523 claims
  • Antibiotics2%35 of 1,523 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,0832024: 1,1567%

Drugs named by CMS: 30 in 2024, 31 in 2023.

See all prescribing by Dr. Khalid

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Aysha Khalid scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Khalid for performance year 2024, reported as part of a group. Dr. Khalid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khalid as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Khalid's MIPS scores, performance year 2024

  • 100of 100Final score
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Khalid by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Aysha Khalid has 14 publications on record

Dmand AI links 14 papers to Dr. Khalid, published from 2016 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Osteoblasts, Osteogenesis and Cell Differentiation. Dr. Khalid has published most often in Bone. Dr. Khalid's most frequent co-authors are Jian Feng, MD, Christina Ann Gurnett, MD and Amy F. Lewanda, MD.

Papers14
Years published2016 to 2024

Dr. Khalid's papers by year, 2016 to 2024

Topics Dr. Khalid writes about most

  • Osteoblasts
  • Osteogenesis
  • Cell Differentiation
  • Core Binding Factor Alpha 1 Subunit
  • Gene Expression Regulation
  • Mesenchymal Stem Cells
  • Osteoclasts
  • Bone and Bones

Dr. Khalid's most frequent co-authors

Recent publications by Dr. Khalid

See all 14 publications and co-authors

See who Dr. Khalid researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Khalid works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Aysha Khalid received $5,112 in industry payments from 2016 to 2025

CMS Open Payments shows 239 general payments to Dr. Khalid from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Bristol-Myers Squibb Company paid the most, $397.

General payments to Dr. Khalid by program year, 2016 to 2025

General payments to Dr. Khalid by kind, 2016 to 2025

$5.1Kin total
  • Food and beverage$4,80394%
  • Education$3106%

Companies that paid Dr. Khalid the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Khalid

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Aysha Khalid graduated from Ross University School of Medicine

Dr. Khalid graduated from Ross University School of Medicine in 2001.

  1. Medical schoolRoss University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Aysha Khalid's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Aysha Khalid

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Aysha Khalid's NPI number?

Dr. Aysha Khalid's NPI number is 1952522732. It was assigned on May 1, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Aysha Khalid?

Dr. Aysha Khalid is a hematologist and oncologist in East Brunswick, New Jersey. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Aysha Khalid practice?

Dr. Khalid practices at 629 Cranbury Rd, East Brunswick, NJ 08816. Dr. Khalid's primary practice is Astera Cancer Care - East Brunswick in East Brunswick, New Jersey. Dmand AI also links Dr. Khalid to 2 hospitals, 2 group practices and clinics and 1 medical group.

What is Dr. Aysha Khalid's office phone number?

The practice phone on file for Dr. Khalid is (732) 390-7750.

What is Dr. Aysha Khalid's medical license number?

Dr. Khalid holds New Jersey license 25MA08205500.

Which hospitals is Dr. Aysha Khalid affiliated with?

Dr. Khalid is affiliated with JFK University Medical Center. Dmand AI links Dr. Khalid to 2 more hospitals.

What medical group is Dr. Aysha Khalid part of?

Dr. Khalid is linked to Astera Cancer Care. Dmand AI links Dr. Khalid to 1 more medical group.

Does Dr. Aysha Khalid accept Medicare?

Yes. CMS data shows Dr. Khalid billed Medicare for 35,388 services in 2024, and Dr. Khalid accepts Medicare assignment.

Does Dr. Aysha Khalid offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Khalid as offering telehealth services.

What is Dr. Aysha Khalid's MIPS score?

Dr. Khalid's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Aysha Khalid see?

CMS counts 534 Medicare patients who saw Dr. Khalid in 2024, with an average age of 76.

What services does Dr. Aysha Khalid bill to Medicare?

In 2024, Dr. Khalid's most billed Medicare services were injected or infused drug (J1439), injected or infused drug (J1100) and hospital inpatient care (99232).

Where did Dr. Aysha Khalid go to medical school?

Dr. Khalid graduated from Ross University School of Medicine in 2001.

What drugs does Dr. Aysha Khalid prescribe most?

In 2024 Medicare Part D data, Dr. Khalid's most prescribed drugs by claims were Anastrozole, Eliquis and Procrit.

Has Dr. Aysha Khalid received payments from drug or device companies?

CMS Open Payments shows $5,112 in general payments to Dr. Khalid from 56 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.

How long has Dr. Aysha Khalid been practicing?

Dr. Khalid graduated from medical school in 2001, 25 years ago.

Does Dr. Aysha Khalid do research?

Dmand AI links 14 publications to Dr. Khalid, published from 2016 to 2024.

Who does Dr. Aysha Khalid publish with?

Dr. Khalid's most frequent co-authors are Jian Feng, MD (1 shared paper), Christina Ann Gurnett, MD (1 shared paper) and Amy F. Lewanda, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in New Jersey by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)